Clinical Trials in North Carolina

Showing 2601-2620 of 17,526 trials

A Prospective Non-concurrent Controlled Evaluation of Open and MAS® PLIF

NCT01640977

The study is a prospective non-concurrent controlled observational evaluation of short-term operative results. As such, study sites will capture perioperative (through 6-week postoperative follow-up) case data associated with 10 standard open PLIF (posterior lumbar interbody fusion) procedures. After this open experience, these same sites will capture the corresponding data from 10 subsequent cases where the MAS (Maximum Access Surgery) PLIF variant was performed. The data from both series of cases will be compiled to identify similarities and differences between the techniques.

Lumbar Degenerative Disc Disease

NuVasive67 participantsStarted Jun 2012

Greensboro, North Carolina, United States • Greensboro, North Carolina, United States • York, Pennsylvania, United States +1 more locations

RECRUITINGPhase 338 miles

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

NCT07300839

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a group that receives a vaccine that doesn't contain an ingredient to protect against COVID-19 (placebo).

COVID-19SARS-COV-2 Infection

BioNTech SE25,500 participantsStarted Dec 2025

Anniston, Alabama, United States • Athens, Alabama, United States • Birmingham, Alabama, United States +205 more locations

A Prospective Non-concurrent Controlled Evaluation of Open and MAS® PLIF

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

Find Trials by Condition in North Carolina

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

Stroke Thrombectomy and Aneurysm Registry

Prevention of Colorectal Cancer Through Multiomics Blood Testing

Study of Pregnancy And Neonatal Health (SPAN)

Clinical and Molecular Studies in Families With Inherited Eye Disease

SpineTRACK Registry - Spinal Outcomes Registry

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of Age

Observational Study Protocol: LIVER-R

A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer

IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)

Neuroprognostication Bias: A Collaboration to Reduce the Impact of Self-fulfilling Prophecy in Cardiac ARrEst

A Study of YL242 in Subjects With Advanced Solid Tumors

Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease

An Observational Study of Patients With Moderate Parkinson's Disease

Tensi+ for Treating Overactive Bladder: A Randomized Controlled Trial

Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)

A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)